Zevra Therapeutics, Inc.
ZVRA
$8.31
$0.374.66%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -22.24% | 81.44% | -6.56% | -22.17% | -18.81% |
Total Receivables | 34.90% | -12.93% | 7.73% | -52.21% | -66.54% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 78.03% | -15.26% | 43.79% | 2.41% | 9.81% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -13.49% | 63.31% | -3.18% | -27.66% | -36.55% |
|
|||||
Total Current Assets | -13.49% | 63.31% | -3.18% | -27.66% | -36.55% |
Net Property, Plant & Equipment | -29.01% | -10.20% | -10.78% | 16.71% | 13.88% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -- |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -- |
Total Other Intangibles | -2.29% | 6.73% | -2.28% | -2.21% | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 22.82% | -16.30% | -22.09% | 43.05% | 1,479.49% |
Total Assets | -7.01% | 32.65% | -4.54% | -12.21% | 23.99% |
|
|||||
Total Accounts Payable | -46.55% | 19.62% | -10.24% | 62.90% | 17.74% |
Total Accrued Expenses | 103.23% | 26.29% | 52.02% | -76.53% | 108.65% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -22.22% | -9.40% | 2.23% | 7.37% | 24.83% |
Total Finance Division Other Current Liabilities | 244.09% | -64.68% | 26.04% | -17.23% | 716.83% |
Total Other Current Liabilities | 244.09% | -64.68% | 26.04% | -17.23% | 716.83% |
Total Current Liabilities | -1.21% | 13.24% | 1.81% | -59.43% | 239.50% |
|
|||||
Total Current Liabilities | -1.21% | 13.24% | 1.81% | -59.43% | 239.50% |
Long-Term Debt | 1.02% | 0.99% | 35.65% | 748.76% | -88.45% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -22.98% | -11.21% | -22.84% | 54.61% | -11.80% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 59.50% | 23.46% | -21.64% | -7.58% | 477.42% |
Total Liabilities | 13.70% | 8.80% | 9.24% | -7.24% | 54.47% |
|
|||||
Common Stock & APIC | 0.89% | 14.82% | 0.69% | 0.72% | 13.04% |
Retained Earnings | -7.61% | -7.61% | -4.79% | -4.16% | -17.77% |
Treasury Stock & Other | 6.72% | -5.07% | 2.58% | 1.67% | 1.58% |
Total Common Equity | -43.15% | 114.82% | -33.47% | -21.09% | -8.31% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -43.15% | 114.82% | -33.47% | -21.09% | -8.31% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -43.15% | 114.82% | -33.47% | -21.09% | -8.31% |
|